Other economic research events

The USPTO’s Office of the Chief Economist (OCE) organizes and participates in symposia, roundtables, and workshops around the country to facilitate discussion on specialized topics in intellectual property. These past events are listed here for your reference.

October 2017

PatentsView Workshop on Engaging User Communities

Event web site: PatentsView Workshop of Engaging User Communities

At this event, the USPTO officially launched the PatentsView Community Site, updated data visualization with export functionality, and new data fields that can be accessed across PatentsView tools. This year’s updates were based on feedback gathered by the user community at the 2016 PatentsView workshop. The new community site includes a moderated forum for user inquiries and a Data in Action page for sharing analyses, visualizations, and publications.

October 2016

PatentsView Workshop on Engaging User Communities

Web Tool: PatentsView Query Builder
Event web site: PatentsView Workshop of Engaging User Communities
Webcast: Workshop recording

The theme of the workshop was “New Tools for Open Patent Data.” The USPTO officially launched a new PatentsView data query builder at the workshop. This query builder allows users to easily request and download subsets of PatentsView data. The PatentsView database incorporates the new inventor disambiguation algorithm developed at the 2015 workshop by Nicholas Monath and colleagues at UMass Amherst. Further information is available at the PatentsView website

September 2016

USPTO Cancer Moonshot Challenge

Director's Blog: USPTO Launches Cancer Moonshot Challenge
Data: Cancer Moonshot Patent Data
Event page: Cancer Moonshot Challenge - Info Session

The USPTO enlisted the public’s help to leverage our intellectual property data, often an early indicator of meaningful research and development, and combine it with other economic and funding data. Participants in the challenge had the opportunity to leverage USPTO Cancer Moonshot patent data to reveal new insights into investments around cancer therapy research and treatments.